v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
OPERATING ACTIVITIES    
Net income (loss) $ (95,496) $ (76,879)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Share-based compensation expense 16,980 14,887
Depreciation and amortization expense, including amortization of deferred financing costs 93,915 98,829
Deferred rent (4,820) (5,544)
(Income) loss from unconsolidated real estate ventures, net 960 (499)
Amortization (accretion) of market lease intangibles, net 164 (34)
Amortization of lease incentives 1,022 6,940
Loss on the extinguishment of debt, net   5,053
Impairment loss 45,565 40,296
Gain on the sale of real estate, net (20,790) (42,369)
Loss on operating lease and other receivables 375 957
(Income) loss from investments, net (4,321) 270
Return on capital from unconsolidated real estate ventures 881 864
Other non-cash items 152 2,148
Changes in operating assets and liabilities:    
Tenant and other receivables (3,706) 1,104
Other assets, net 1,215 (1,915)
Accounts payable and accrued expenses (10,011) (12,213)
Other liabilities, net (2,841) (143)
Net cash provided by operating activities 19,244 31,752
INVESTING ACTIVITIES    
Development costs, construction in progress and real estate additions (43,145) (62,417)
Acquisition of real estate   (42,713)
Proceeds from the sale of real estate 46,582 381,607
Proceeds from derivative financial instruments 3,631 4,967
Payments on derivative financial instruments   (7,995)
Distributions of capital from unconsolidated real estate ventures and other investments 3,977 701
Investments in unconsolidated real estate ventures and other investments (4,096) (3,426)
Net cash provided by investing activities 6,949 270,724
FINANCING ACTIVITIES    
Borrowings under mortgage loans 24,391 275,027
Borrowings under revolving credit facility 85,000 631,000
Repayments of mortgage loans (3,008) (505,897)
Repayments of revolving credit facility (80,000) (490,000)
Proceeds from derivative financial instruments   7,835
Payments on derivative financial instruments (1,581) (2,161)
Debt issuance and modification costs (1,109) (5,207)
Redemption of noncontrolling interests (1,077)  
Proceeds from common shares issued pursuant to ESPP 452 487
Common shares repurchased (28,401) (372,848)
Dividends paid to common shareholders (20,666) (27,221)
Distributions to redeemable noncontrolling interests (7,030) (5,721)
Proceeds from the sale of interest in consolidated real estate venture 11,813 100,000
Distributions to noncontrolling interests (200)  
Net cash used in financing activities (21,416) (394,706)
Net increase (decrease) in cash and cash equivalents, and restricted cash 4,777 (92,230)
Cash and cash equivalents, and restricted cash, beginning of period 103,290 183,192
Cash and cash equivalents, and restricted cash, end of period 108,067 90,962
SUPPLEMENTAL DISCLOSURE OF CASH FLOW AND NON-CASH INFORMATION    
Cash paid for interest (net of capitalized interest of $778 and $3,128 in 2026 and 2025) 65,815 62,995
Accrued capital expenditures 27,639 36,479
Write-off of fully depreciated assets 13,242 17,805
Cash paid for income taxes 7 61
Contribution of land to unconsolidated real estate venture 9,906  
Redemption of OP Units for common shares 11,034 10,854
Redeemable noncontrolling interests redemption value adjustment (6,683) 32,624
Cash paid for amounts included in the measurement of lease liabilities for operating leases $ 2,712 $ 3,329